Akari Therapeutics Plc
Akari Therapeutics Plc is a novel anti-inflammatory, first-in-class synthetic drugs founded in 2015.
3
Funding Rounds
$34.4m
Money raised
Overview
Akari Therapeutics Plc is a novel anti-inflammatory, first-in-class synthetic drugs founded in 2015.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company Akari Therapeutics Plc has raised a total of $12.5m in funding over 3 rounds.
Key Insights:
- Akari Therapeutics Plc funding round, October 2013: $12.5m
- Akari Therapeutics Plc funding round, March 2020: $9.55m
- Akari Therapeutics Plc funding round, July 2021: $12.32m
Akari Therapeutics Plc funding round, October 2013
$12.5m
Akari Therapeutics Plc funding round, March 2020
$9.55m
Akari Therapeutics Plc funding round, July 2021
$12.32m
Industries
Akari Therapeutics Plc is active in the following industries: